"Medicare's Potential Price Controls on Medications"

Medicare will directly set the prices of covered prescription drugs for the first time in history as part of the Inflation Reduction Act. The Centers for Medicare & Medicaid Services (CMS) plans to publish the list of the first 10 drugs subject to price controls in September. Some drug manufacturers, including Merck, Johnson & Johnson's Janssen Pharmaceuticals, and Bristol Myers Squibb, have disclosed that their medications, such as Januvia, Xarelto, Eliquis, and Opdivo, will be subject to controlled prices. This move has been met with opposition from some drug companies, who have sued the federal government over the program.